http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007211-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d06a96cba78a435ebcfe8dc0a4cd119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b52c6ef0e94a75256ae7b6b243173f1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
filingDate 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14353127af469a545bda9c6cba2a7675
publicationDate 2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005007211-A3
titleOfInvention Medical devices with proteasome inhibitors for the treatment of restenosis
abstract Methods, compositions and devices for inhibiting restenosis are provided. Specifically, proteasome inhibitor compositions and medical devices useful for the site specific delivery of proteasome inhibitors are disclosed. In one embodiment the medical device is a vascular stent coated with a proteasome inhibitor selected from the group consisting of a boronic acid, a C-terminal peptide aldehyde and derivatives and analogues thereof. In another embodiment an injection catheter for delivery an anti-restenotic effective amount of proteasome inhibitor to the adventitia is provided.
priorityDate 2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5780454-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002188037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0010552-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002085549-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431904250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139620

Total number of triples: 26.